SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001140361-21-017917
Filing Date
2021-05-18
Accepted
2021-05-18 17:15:49
Documents
1
Group Members
AVISTA ACQUISITION, LLCAVISTA CAPITAL MANAGING MEMBER IV, LLCAVISTA CAPITAL PARTNERS (OFFSHORE) IV, LPAVISTA CAPITAL PARTNERS IV GP L.P.AVISTA CAPITAL PARTNERS IV, L.P.DAVID BURGSTAHLERTHOMPSON DEAN

Document Format Files

Seq Description Document Type Size
1 SC 13D/A brhc10024746_sc13da.htm SC 13D/A 248405
  Complete submission text file 0001140361-21-017917.txt   250300
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Subject) CIK: 0001661181 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89667 | Film No.: 21937218
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 65 EAST 55TH STREET 18TH FLOOR NEW YORK NY 10022
Business Address 65 EAST 55TH STREET 18TH FLOOR NEW YORK NY 10022 212 593-6900
Avista Acquisition Corp. (Filed by) CIK: 0001661187 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A